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have lower body mass index (BMI) [5] but obese patients have been shown to gain the most from laparoscopy [6] . Obesity is not only a major risk factor for the development of EC [7] but it increases postoperative complications, especially wound infection, and is associated with factors such as hypertension, heart disease and diabetes which add additional surgical risk.
Despite the prevalence of obesity in EC, there are surpris ingly few reports of laparoscopy in populations with a high median or mean BMI, ≥35 [5, 810] or ≥30 [1116] and the pre cise influence of BMI on complication rates and on the surgery performed within these series has not been clearly delineated.
Our objective was to analyze experience with laparoscopy and la pa rotomy for EC within an obese population to deter mine the effect of BMI on postoperative complications and the performance of lymph node dissection (LND).
MATERIALS AND METHODS
This was a retrospective cohort study. After approval of the In s titutional Review Board all women undergoing sur gi cal treat ment for EC within a Cancer Centerbased gyne co lo gic on co logy service between November 2003 and De cem ber 2008 were identified. Relevant medical records were retrie v ed between June 2009 and December 2010. Followup was either in the Cancer Center or nearer to home. Where ne ce ssa ry followup information was obtained from the hospital tu mor registry or from patients in person. Histology details were obtained from the surgical pathology reports and tumor conference records. For analysis, highrisk histologic subtypes (serous, clear cell or mixed containing serous or clear cell) were grouped together under serous, whereas endometrioid histology included endometrioid with mucinous elements.
Surgery was performed by four gynecologic oncologists within a residency training program. The decision to perform la pa ro scopy or laparotomy was by surgeon preference but by the end of the study period all patients with clinically early stage disease (confined to the uterus) were selected for la pa ro scopy provided that they were considered capable of tolerating the procedure. Laparotomy utilized either a midline or low transverse incision, with panniculectomy in a minority to fa ci litate surgery. The decision to perform a LND was based on prognostic factors (grade of primary tumor, depth of myo metrial invasion, size of primary tumor) and the feasibility of surgery based on the patient's medical condition and body habitus. LND was preferred for tumors of grade 3, grade 1 and 2 with outer half myometrial invasion, and tumors with obvi ous cervical involvement, spread outside the uterus or of high risk (serous, clear cell) subtype.
The laparoscopic technique of obtaining entry to the perito neal cavity most commonly consisted of direct entry using a 5 mm Optiview port (Ethicon Endosurgery, Cincinnati, OH, USA) in the left upper quadrant of the abdomen followed by place ment of a 10 mm camera port at the umbilicus, 5 mm ports in both iliac fossa and a 10 mm port suprapubically. Surgical specimens were normally removed through the vagina whilst larger specimens were removed using an extended port inci sion. Lymph node (LN) were removed in a bag through a 10 mm port or the vagina. Laparoscopic hysterectomy was early on performed by laparoscopicassisted vaginal hyste rectomy (LAVH) and later by total laparoscopic hysterectomy (TLH) and roboticassisted (TRH) (Intuitive Surgical Inc., Sunnyvale, CA, USA) with the entire procedure performed from above. For the laparoscopic approach it was standard practice to use a RUMI uterine manipulator (CooperSurgical Inc, Trumbull, CT, USA).
For analysis, patients were divided into two groups: those treated by laparotomy and those in whom the intention was to perform the surgery laparoscopically. Patients were classi fied as having their surgery 'converted' to laparotomy when ever laparoscopy was discontinued so that surgery could be completed through a laparotomy incision or an extension of a regular port incision to remove the uterus. BMI was cal culated using the formula BMI=weight (kg)/[height (m)] 2 . A presumptive FIGO stage based on the parameters available was assigned to patients who did not undergo complete sur gical staging. All adverse events were recorded and divided into intraoperative and postoperative within two months of surgery. Postoperative complications were graded according to the National Cancer Institute Common Toxicity Criteria for Adverse Events grading system (CTCAE ver. 4.03) [17] . The degree of wound pain was recorded as present or absent. Wound separation included wounds that opened spontane ously and those that were opened in order to assist healing. Analysis was performed by the 'intention to treat' basis.
Statistical methods
The distributions for patient characteristics and different com pli cations between laparoscopy and laparotomy groups were compared using the Wilcoxon rank sum test for con tinuous variables and χ²test (or Fisher's exact test when the expected frequency within any cell was less than 5 in a 2×2 www.ejgo.org 171 [19] was used to estimate the overall survival (OS) and progression free survival (PFS). Sur vival differences were compared using the unweighted log rank test [20] . The OS time was determined as the time from surgery until death or last followup evaluation. The PFS time was determined as the time from surgery until the first ad verse event (i.e., disease progression, second malignancy, or death due to any cause). All calculations were performed with SAS (SAS Institute Inc., Cary, NC, USA) [21] . Significantly more patients in the laparotomy group unde r went additional procedures other than hysterectomy and/or BSO, PALND, or PLND (Table 1) : 24/103 (23.3%) versus 2/65 (3%) (p<0.01). In the laparotomy group, the 29 additio nal procedures performed in 24 patients were: partial omentectomy (n=10), hernia repair (n=6), panniculectomy (n=3), small bowel re section (n=2), appendectomy (n=2), colostomy repair (n=1), omental J flap (n=1), liver biopsy (n=1), colposacropexy (n=1), and urethral sling procedure and upper vaginectomy (n=1). In the laparoscopy group, the additional procedures were urethral sling procedure (n=1) and umbilical hernia repair (n=1). There was no significant difference in the proportion of pa tients undergoing previous abdominal surgery in the la pa ro scopy and laparotomy groups (24/ The median number of PALN removed was greater in the la pa ro scopy versus laparotomy group but there was no diffe ren ce in the median number of pelvic LN (PLN), or overall number of LN removed (Table 1) .
RESULTS

Between
Estimated blood loss, time to flatus, and duration of hospital stay were less in the laparoscopy group whilst the duration of surgery was longer (Table 1) . After laparotomy the postopera tive hemoglobin (Hb) was lower than after laparoscopy (Table  1 ). There were no portsite metastases and no vaginal dehis cences in the laparoscopy group. Four nonsevere intraoper ative complications occurred in each group. In the laparotomy group they were: colotomy repaired primarily and protected with omental J flap, bleeding from the inferior vena cava (n=2) and hypotension whilst in the laparoscopy group they were: bladder muscular injury repaired, bleeding from epigastric artery caused by the suturing device at closure, small vaginal tear while removing large uterus and hypercarbia causing temporary interruption of the procedure. There were 3 peri operative deaths, one after laparoscopy (sudden collapse at home on postoperative day 8 with cause of death given as cardiac arrest) and two after laparotomy (one a cardiac ar 
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rest on postoperative day 4 and the other sudden collapse at home on postoperative day 47). No post mortems were per formed.
Complications of any grade excluding pain and grade ≥3 com plications were significantly more common after la pa ro tomy (p=0.01, p≤0.01) Table 2 . Only two patients ex peri en ced grade ≥3 complications after undergoing the entire procedure laparoscopically, one pneumonia and the other su dden death at home postoperative day 8. Although there was no signifi cant difference in the incidence of postoperative anemia ≥3, 14 (13.6%) received a postoperative trans fusion after laparoto my versus 3 (4.6%) after laparoscopy (p=0.06) with all 3 being converted to laparotomy (Table 2) . Wound complications and complications of any kind ≥3 were significantly more com mon in the 12 patients in the laparoscopy group who were converted to laparotomy com pared to the 53 patients in the laparoscopy group who under went surgery without conver sion. In contrast, there was no diffe rence in these complica tions between the 12 patients con verted from laparoscopy to laparotomy and the 103 pa tients in the laparotomy group (Table 2) . Six (5.8%) patients in the laparotomy group under went a further operative pro cedure, 5 wound debridements and one colostomy for a rectovaginal fistula. No patients in the laparoscopy group needed a further surgery (p=0.08). Analysis of the correlation between BMI and continuous characteristics by surgical approach (Table 4) showed that in the laparoscopy group increasing BMI did not impact the du rations of surgery or hospital stay, time to flatus or number of PALN and PLN removed nor the estimated blood loss, whereas it was associated with a trend towards a lower postoperative Hb level (p=0.07). In the laparotomy group increasing BMI was associated with longer duration of surgery and lower number of PALN removed.
In a logistic model to examine the effect of BMI (≥36 and<36) on complications within the laparotomy and laparoscopy groups, there was no relationship between complications and BMI within the laparoscopy group. In contrast, in the laparo tomy group, wound complications of any kind (p<0.01), grade ≥3 wound (p≤0.01), grade ≥3 wound infection (p=0.01) and wound separation (p=0.02) were all significantly related to BMI.
In the laparoscopy group within stage I (Table 3) there was an inverse relationship between the performance of LND of any kind (p=0.01), PALND (p=0.03), and PLND (p<0.01) and in creasing BMI in contrast to the laparotomy group where there was a trend only.
The overall median followup time from surgery was 17.2 months and 17.4 months for patients who were alive at the time of the last followup. For FIGO stage I (Table 5 ), OS and PFS were similar between groups (p=0.12, p=0.39) after me dian followup of 12.8 months (range, 0 to 59.3 months). As expected with the higher incidence of patients with FIGO stage ≥ II the OS was worse in the laparotomy group (data not shown).
DISCUSSION
The key results in this study are that increasing BMI signifi cantly impacted the decision to perform LND in patients under going laparoscopic surgery but it did not impact post operative morbidity. The report contains a population with a high median and mean BMI (35.0 and 36.0) with over 50% in both the laparoscopy and laparotomy groups being obesity class II or greater according to the World Health Organization International Classification of Obesity in which BMI ≥30 (over weight), 3034.99 (class I), 3539.99 (class II), and ≥40 (class III) [22] . In contrast to laparotomy, many reports of laparoscopy for EC either specifically exclude women with high BMI [23] or the local populations have a low prevalence of obesity [24] . Studies reporting the use of laparoscopy for EC where the me dian or mean BMI are ≥30 are detailed in Table 6 . We classified the complications of surgery according to the CTCAE ver. 4.03 [17] . Only one other study has used an earlier version of this grading system [23] which standardizes the reporting of complications and facilitates comparisons and 174 www.ejgo.org statistical analysis. The uni ver sal ado p tion of this system in future would avoid the diffi cul ties of com paring complication rates when either no [5, 6, 8, 1214, 16, 2536] , subjective [15, 24] or institutional [9] classi fi ca tions are used. Its use should be encouraged.
In our series overall complications occurring during and after laparoscopy surgery were not related to the BMI. Two reports amongst the few in the literature that include populations with a high median or mean BMI ≥35 [5, 810] or ≥30 [1116] (Table 6) came to a similar conclusion [13, 14] although an other reported an increase in complications within a sub set of patients having age>65 years, weight >80 kg, a BMI>30 with at least one of the following comorbidities: dia betes, hyper tension or cardiorespiratory failure [11] . The overall lack of re lationship between BMI and complications after laparoscopy for EC is in marked distinction to patients undergoing laparot omy where patients with BMI ≥36 have a significantly greater incidence of wound complications including severe infection, wound separation and likelihood of postoperative transfusion. This association is well known in patients undergoing lapa rotomy for benign conditions and EC [32] . Since the greatest benefits from laparoscopy are seen in patients with high BMI we agree with others that it should be the initial approach of choice for such patients [11, 32] .
Our conversion rate of 18.5% is high in relation to some recent studies (Table 6 ) but is within the literature range of 036.4% [5, 8, 9, 1113, 16, 23, 2528, 3035, 37, 38] . This is almost certainly due to the learning curve since in 6 of the cases (ad hesions [n=3], for staging [n=2], inadequate exposure due to subperitoneal fat [n=1]), conversion would probably now be avoided as a result of increased experience. This would reduce the complete conversion rate (excluding laparotomy to re move large uteri) to 3 of 65 = 4.6% which would include those with obesityrelated problems such as inability to tolerate the head down position and pneumoperitoneum. Of note is that, in this series, patients who were converted to laparotomy from laparoscopy had complications similar to those under going planned laparotomy (Table 2) .
Childers et al. [39] was the first to report that obesity was the limiting factor in performing LND among women with EC. In our series, performance of both PALND and PLND was in versely related to the BMI (Table 3 ). In series containing popu lations with high median or mean BMI (Table 6 ) there was re ported to be no influence overall [13] or no influence on PLND specifically [6] . With regard to PALND, Tozzi et al. [6] reported 'minimal influence' and Scribner et al. [8] suggested that there was 'probably' an effect on PALND because of difficulties in access in obese patients, backed up by a conversion rate of 36.4% with the commonest reason being obesity. Eltabbakh et al. [5] reported that 5% of patients did not undergo PALND due to 'lack of exposure'. Others have reported the increased difficulty in performing PALND with increasing weight [30] and when the weight is >160 kg [32] . Even in papers that do not report on the impact of BMI on the performance of LND it is possible to infer an effect of BMI by examining the rate of conversion and the reasons for conversion. In the recent Gynecologic Oncology Group study the conversion rate was 25.8% of 1,682 patients randomized to undergo laparoscopy However, it appears that the technical difficulties of PALND in the obese can be overcome and three studies (Table 6) reported rates of PALND of 90100% [1416] with low rates of conversion to laparotomy 9.4% and 4.7% [14, 16] indicating that PALND is feasible in the majority of this population. BMI probably played a role in the performance of PALND because the reason for conversion in 2 of 10 patients in one study was inadequate exposure due to adhesions and obesity [16] .
This report clearly has significant limitations in that it was retrospective, it included patients treated with LAVH, TLH, and TRH performed during transition from laparotomy to laparos copy surgery for EC within a gynecologic oncology group of 4 surgeons, and it included no prospective analysis of pain or quality of life. However, these do not negate the significant findings that the BMI did not affect the rate of complications within the group undergoing laparoscopy, or the number of LN removed when a LND was performed. With regard to as sessing the influence of the BMI on the decision to perform a LND, there were no mandated criteria for performance of LND or contemporary documentation of the reasoning be hind the decision whether or not to perform LND but there was a group consensus with regards to the factors indicating the need for LND. This supports the finding that the decision whether or not to perform LND was, in part, related to the BMI of the patient. This has previously been only alluded to in other series including populations with a high BMI [5, 8, 3032] .
The question arises as to how to manage patients with a high BMI who are at increased risk for LN metastasis due to factors such as poor grade and deep myometrial invasion, cervical involvement and highrisk histologic subtypes. In such patients access to the paraaortic nodal bed is essential and presents more of a problem in these patients than pelvic node dissection. The data in this series applies only to the per formance of transperitoneal LND and it may be that in such patients an extraperitoneal approach may give more reliable access to the paraaortic nodes up to the left renal vein and duodenum.
Within our experience, for patients undergoing laparoscopic surgery for EC, increasing BMI did not impact postoperative complications or number of LN resected. However, the BMI did influence the decision to perform LND at laparoscopy.
